Enter one or more keywords to search for using the Zoom Search Engine.
Note that '*' and '?' wildcards are supported.
78 results found containing all search terms. 752 results found containing some search terms.
... within 6 months of discontinuation (Level A) . Physicians and people with MS choosing to switch from natalizumab to ï ngolimod should initiate treatment within 8 to 12 ...
Terms matched: 1 - Score: 23 - 26 Oct 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/Multiple_Sclerosis_Agents_2020-12.pdf
... ; November 2017. ⢠Post RM. Bipolar disorder in adults: choosing maintenance treatment. UpToDate website. www.uptodate.com. Updated November 9, 2019. ...
Terms matched: 1 - Score: 10 - 26 Oct 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/Anticonvulsants_2020-12.pdf
... Presentation Presented to NV DUR Board on October 22, 2020 DRUG USE REVIEW BOARD MCO PRIOR AUTHORIZATION CRITERIA REVIEW FORM Clinical criteria for drugs or drug classes listed on ...
Terms matched: 1 - Score: 63 - 25 Sep 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/Anthem_DUR_Binder_Oct_2020.pdf
... - 24 Standard DUR Reports - 26 Topical Antipruritics Clinical Presentation DRUG USE REVIEW BOARD MCO PRIOR AUTHORIZATION CRITERIA REVIEW FORM Clinical criteria for drugs or drug classes listed on ...
Terms matched: 1 - Score: 60 - 25 Sep 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/SilverSummit_DUR_Binder_Oct_2020.pdf
... Drug Use Review Board Meeting OCTOBER 22, 2020 2020 3 DRUG USE REVIEW BOARD MCO PRIOR AUTHORIZATION CRITERIA REVIEW FORM Clinical criteria for drugs or drug classes listed on ...
Terms matched: 1 - Score: 60 - 25 Sep 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/Health_Plan_of_Nevada_DUR_Binder_Oct_2020.pdf
... ) . Physicians and people with MS choosing to switch from natalizumab to ï ngolimod ... CMS. The Fee-for- Service and MCO Surveys will be presented at the next ...
Terms matched: 2 - Score: 31 - 25 Sep 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/FFS_DUR_Binder_Oct_2020.pdf
... , program oversight of managed care partners when applicable, and statewide (FFS and MCO) initiatives. The Drug Use Review Board (DUR) is a requirement ...
Terms matched: 1 - Score: 12 - 25 Sep 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/FFS_DUR_Survey_FFY2019.pdf
... within 6 months of discontinuation (Level A) . Physicians and people with MS choosing to switch from natalizumab to ï ngolimod should initiate treatment within 8 to 12 ...
Terms matched: 1 - Score: 23 - 03 Sep 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/Multiple_Sclerosis_Agents_2020-09.pdf
... within 6 months of discontinuation (Level A) . Physicians and people with MS choosing to switch from natalizumab to ï ngolimod should initiate treatment within 8 to 12 ...
Terms matched: 1 - Score: 66 - 17 Aug 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/E-Binder_SSSB_Sept_2020.pdf
... – ª Self directed providers disabilities) $175 billion â – ª Providers that choose to accept funds must attest to the terms and conditions in payments to be ...
Terms matched: 1 - Score: 41 - 14 Aug 2020 - URL: https://www.medicaid.nv.gov/Downloads/provider/Provider_Relief_Fund_Step-by-Step_Provider_Guide.pdf